HEALTH OF WOMAN. 2015.8(104):153–156; doi 10.15574/HW.2015.104.153 

State platelet and plasma hemostasis in women with stable coronary heart disease in early and late postmenopausal period 

Netyazhenko N. V., Yaremenko K. M., Reshot’ko D. O., Solomaha T. O.

A.A. Bogomolets National Medical University, Kiev

Oleksandrivska city clinical hospital, Kiev 

In the article presents data on the comparative analysis of the platelet and plasma hemostasis in women with stable angina who were in a postmenopause. Correlation analysis and got close correlation between serum containing estradiol, progesterone and progesterone estradiol- ratios and indicators induced platelet aggregation and as anticoagulant, fibrinolytic systems of hemostasis and levels of natural anticoagulants in the early postmenopausal period in early postmenopausal women with established CHD stable accompanied prothrombotic and pro-coagulating changes of hemostasis, the severity of which depends on the content in serum levels of estradiol, progesterone and their relationship. 

Key words: stable coronary heart disease, postmenopausal period, platelet hemostasis, plasma hemostasis. 

REFERENCES

1. Баркаган ЗС, Момот АП. 2008. Диагностикая и контролируемая терапия нарушений гемостаза. М, Ньюдиамед-АО:292.

2. Берковская МА, Бутрова СА. 2010. Распространенность нарушений свертывающей и противосвертывающей систем крови у женщин с метаболическим синдромом в постменопаузе. Ожирение и метаболизм 3:21–27.

3. 2013 ESC guidelines on the management of table coronary artery disease: the Task Force on the management of table coronary artery disease of the European Society of Cardiology. Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabate M, Senior R, Taggart DP, van der Wall EE, Vrints CJ; ESC Committee for Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Ryden L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL. 2013. Eur Heart J. 34:2949–3003.

4. Go AS, Mozaffarian D, Roger VL et al. 2013. Heart disease and stroke statistics 2013 update: a report from the American heart association. Circulation. 127:6–245. http://dx.doi.org/10.1161/CIR.0b013e31828124ad; PMid:23239837

5. Harrison P, Mackie I, Mumford A, Briggs C, Liesner R, Winter M, Machin S. 2011. British Committee for Standards in Haematology. Guidelines for the laboratory investigation of heritable disorders of platelet function. British journal of haematology 155;1:30–44. http://dx.doi.org/10.1111/j.1365-2141.2011.08793.x; PMid:21790527

6. Kavita Sh, Martha G. 2013. Coronary Artery Disease in Women. Global Heart 8(2):105. http://dx.doi.org/10.1016/j.gheart.2013.02.001; PMid:25690374

7. Maas AH, van der Schouw YT, Regitz-Zagrosek V et al. 2011. Red alert for women’s heart: the urgent need for more research and knowledge on cardiovascular disease in women Proceedings of the Workshop held in Brussels on Gender Differences in Cardiovascular disease, 29 September 2010. Eur. Heart. J. 32:1362–1368. http://dx.doi.org/10.1093/eurheartj/ehr048; PMid:21406440

8. Nkonde-Price C, Bender JR. 2015. Menopause and the Heart. Endocrinol Metab Clin North Am. 44(3):559–64. http://dx.doi.org/10.1016/j.ecl.2015.05.005; PMid:26316243

9. Prior JC, Elliott TG, Norman E, Stajic V, Hitchcock CL. 2014. Progesterone therapy, endothelial function and cardiovascular risk factors: a 3-month randomized, placebo-controlled trial in healthy early postmenopausal women. Plos one. 9;1:1–9. http://dx.doi.org/10.1371/journal.pone.0084698

10. Shufelt C, Waldman T, Wang E, Merz CN B. 2015. Female-Specific Factors for IHD: Across the Reproductive Lifespan. Current atherosclerosis reports 17(2):1–9. http://dx.doi.org/10.1007/s11883-014-0481-6; PMid:25620277

11. Stock EO, Redberg R. 2012. Cardiovascular disease in women. Curr Probl Cardiol. 37(11):450–526. http://dx.doi.org/10.1016/j.cpcardiol.2012.07.001; PMid:23047015